A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

NCT06579300 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class

Stopped Strategic considerations

Conditions

Interventions

Sponsor

AbbVie